Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
February 7, 2026
Approximately 5 minutes
Overview of Medical Device Regulation in Estonia
Overview of Medical Device Regulation in Estonia
1. Applicable EU Regulations
Medical devices and in vitro diagnostic medical devices (IVDs) in Estonia are governed directly by:
- Regulation (EU) 2017/745 on medical devices (MDR)
- Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR) These regulations cover requirements for placing devices on the market, conformity assessment, and post-market obligations. Source: Estonian State Agency of Medicines Regulation Page https://www.ravimiamet.ee/en/medical-devices/medical-devices/regulation-field-medical-devices-estonia
2. National Legislation
The Estonian Medical Devices Act provides national additions and specifications to the EU regulations. Transitional provisions related to EUDAMED maintain previous national requirements until full implementation. Source: Estonian State Agency of Medicines Regulation Page https://www.ravimiamet.ee/en/medical-devices/medical-devices/regulation-field-medical-devices-estonia
3. Competent Authority
The State Agency of Medicines (Ravimiamet) is the competent authority responsible for oversight, including receiving notifications and registrations through the Estonian Medical Devices and Appliances Database (EMDDB). There are no fees for registration or notifications. Contact: medicaldevices@ravimiamet.ee Source: Estonian State Agency of Medicines Regulation Page https://www.ravimiamet.ee/en/medical-devices/medical-devices/regulation-field-medical-devices-estonia
4. Notification Obligations
Distributors must notify the Agency within 10 days of first distribution for higher-risk devices, including:
- Class IIa, IIb, III medical devices
- Active implantable devices
- Class B, C, D IVDs
- System or procedure packs Notification for Class I or Class A devices is recommended but not mandatory. Custom-made devices require notification at least 10 days before placing on the market. Source: Estonian State Agency of Medicines Regulation Page https://www.ravimiamet.ee/en/medical-devices/medical-devices/regulation-field-medical-devices-estonia
5. Transition to EUDAMED
Until EUDAMED obligations are fully implemented (expected 28 May 2026), national notification via EMDDB continues. After implementation, manufacturer and device registration (except custom-made) will shift to EUDAMED, while distributor notifications and custom-made device registrations remain national. Source: Estonian State Agency of Medicines Regulation Page https://www.ravimiamet.ee/en/medical-devices/medical-devices/regulation-field-medical-devices-estonia
6. Compliance Requirements
Devices must comply with MDR or IVDR (including transitional provisions) and the Medical Devices Act to be placed on the Estonian market or put into service. Guidance from the Medical Devices Coordination Group (MDCG) should be followed. Source: Estonian State Agency of Medicines Regulation Page https://www.ravimiamet.ee/en/medical-devices/medical-devices/regulation-field-medical-devices-estonia
Ask Anything
We'll follow up with you personally.
Related Articles
Approximately 5 minutes
Market Surveillance of Medical Devices in Estonia
The State Agency of Medicines in Estonia conducts post-market surveillance of medical devices to ensure compliance and safety, focusing on manufacturer responsibility, information exchange, inspections, and user advisories under EU free movement principles.
Approximately 5 minutes
Estonian Guidance on Language Requirements and Market Access for Medical Devices
The Estonian State Agency of Medicines urges manufacturers to prioritize smaller markets like Estonia under MDR/IVDR, clarifying flexible language compliance options through local distributors and subcontractors.
Approximately 5 minutes
Clinical Investigations and Performance Studies for Medical Devices and IVDs in Estonia
Estonia requires applications or notifications to the State Agency of Medicines for clinical investigations (MDR) and performance studies (IVDR), with coordinated scientific and ethical review, fees, and reporting obligations upon completion.